A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
Q&A: George Church’s Genome Up for Auction
Q&A: George Church’s Genome Up for Auction
A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
A founder of the field of synthetic biology is selling data from his own DNA as a nonfungible token, or NFT, through Nebula Genomics, a personal genome company he cofounded.
By combining whole-exome sequencing data with longitudinal electronic health record information for 50,000 individuals, researchers have identified novel disease associations.
From research results to electronic health records, biomedical data are becoming increasingly accessible. How can scientists best capitalize on the information deluge?
The international Global Alliance for Genomics and Health will be using a programming interface developed by the Internet giant to help its stakeholders analyze genomic data.
The names and addresses of people participating in the Personal Genome Project can be easily tracked down despite such data being left off their online profiles.
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.